EFINACONAZOLE (efinaconazole) by Aurobindo Pharma is 12. Approved for azole antifungal [epc]. First approved in 2022.
Drug data last refreshed 19h ago
12.1 Mechanism of Action JUBLIA topical solution is an azole antifungal [ see ]. 12.2 Pharmacodynamics The pharmacodynamics of JUBLIA is unknown. 12.3 Pharmacokinetics Systemic absorption of efinaconazole in 18 adult subjects with severe onychomycosis was determined after application of JUBLIA once…
Worked on EFINACONAZOLE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis